VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that Jeff Baxter, President and CEO, will present at the Canaccord Genuity 39th Annual Growth Conference in Boston, MA, on Thursday, August 8, 2019, at 1:30 PM ET.

A live webcast of the presentation and a subsequent replay may be accessed by visiting the Investors page of VBI’s website at www.vbivaccines.com. A replay of the webcast will be archived on the company’s website for 90 days following the presentation.